Daily non-political popular news in brief.
Second-generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Read more »
Keywords: second-generation, drug-eluting, stent, system, challenges, current, gold, standard, second, generation, drug, eluting, challenge
« Previous | Next »
Similar news on "Second-generation drug-eluting stent system challenges current gold standard":
- Second generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
- ENDEAVOR III Trial reports key findings on new-generation stent
05-10-2007 · EurekAlert!
New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla., will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.
Similar news · Read more »
- Cutting-edge Methods For Analyzing Complex Molecular Interactions
10-05-2006 · ScienceDaily
With the genomes of hundreds of organisms now catalogued, one of the next major challenges is to identify proteins and their interactions. The current issue of CSH Protocols, published online, features two freely available, cutting-edge methods that address this challenge.
Similar news · Read more »
- Studies highlight 'real world' use, safety of drug-eluting stents
03-26-2007 · EurekAlert!
Research presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit 2007 in New Orleans, La, paints a picture of the "real world" use of drug-eluting stents and offers new insight into the connection between blood clotting, or thrombosis, in the stent -- a dangerous complication -- and adherence and responsiveness to anti-clotting medication.
Similar news · Read more »
- Patients who receive drug-eluting stents should continue antiplatelet medications
01-16-2007 · EurekAlert!
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends.
Similar news · Read more »
- Risk and outcome similar for bypass surgery, drug-eluting stents
04-19-2007 · EurekAlert!
Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
Similar news · Read more »
- Lessons from Vioxx case -- New approach needed to restore faith in pharmaceutical industry
01-19-2007 · EurekAlert!
The pharmaceutical industry, academia and government agencies need to work together to restore faith in drug development, say doctors in this weeks' BMJ. They argue that the recent litigation over the drug Vioxx, produced by Merck and Co. Inc., has highlighted the failings of the current system, which can be open to abuse.
Similar news · Read more »
- DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
03-15-2007 · EurekAlert!
As interest in the rising number of newly characterized microbial genomes mounts, powerful computational tools become critical for the management and analysis of these data to enable strategies for such challenges as harvesting the potential of carbon-neutral bioenergy sources and coping with global climate change. The Integrated Microbial Genomes (IMG) data management system developed by the U.S. Department of Energy Joint Genome Institute (DOE JGI) addresses this challenge with the release of version 2.1.
Similar news · Read more »
- SCAI issues clinical alert on drug-eluting stents and late thrombosis
01-11-2007 · EurekAlert!
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with drug-eluting stents. The document follows hearings held by the FDA's Circulatory Systems Device Panel. SCAI's clinical alert focuses on careful patient selection, meticulous stent implantation, and consistent use of medications to prevent the delayed formation of blood clots that can block blood flow to the heart.
Similar news · Read more »
- Should children be permitted to get genetic testing for BRCA 1/2 mutations?
01-15-2008 · EurekAlert!
It's an ethical dilemma with serious implications. Should children be tested for gene mutations that predispose them to developing breast cancer and/or ovarian cancer later in life? New research suggests the next generation of parents may support testing minors even when any steps to reduce that risk will be postponed until adulthood -- a finding that challenges current policies.
Similar news · Read more »
